Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis.
第一作者:
Matthias,Jürgens
第一单位:
Department of Medicine II, Grosshadern, Ludwig-Maximilians-University Munich, Munich, Germany.
作者:
医学主题词
成年人(Adult);抗体, 抗中性白细胞胞质(Antibodies, Antineutrophil Cytoplasmic);抗体, 单克隆(Antibodies, Monoclonal);结肠切除术(Colectomy);结肠炎, 溃疡性(Colitis, Ulcerative);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);女(雌)性(Female);胃肠病用药(Gastrointestinal Agents);遗传变异(Genetic Variation);基因型(Genotype);人类(Humans);Logistic模型(Logistic Models);男(雄)性(Male);受体, 白细胞介素(Receptors, Interleukin);缓解诱导(Remission Induction);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome)
DOI
10.1038/ajg.2010.95
PMID
20197757
发布时间
2024-01-09
- 浏览12
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



